In recent years Pseudomonas aeruginosa has assumed an important role as a causative organism in intrahospital epidemics and as an increasingly frequent cause of death from bacterial sepsis (4, 5) . These infections have been difficult to treat because of their resistance to most of the commonly used antibiotics and the necessity to resort to more toxic agents. Until quite recently, the polymyxins (polymyxin B and colistin) were the only agents which had useful in vitro activity against most strains of of P. aeruginosa. However, the advent of gentamicin and carbenicillin has made available less toxic agents with greater antibacterial activity against these infections.
Strains of P. aeruginosa recently isolated from specimens of infected materials submitted to the bacteriology laboratory of the Boston City Hospital have been collected on several occasions in the past and tested for susceptibility to available and potentially useful antibiotics (7, 15, 24) . have been included during studies of the activity of individual antibiotics, particularly new ones while under clinical trial (3, 10, 20) . Other chemically related antibiotics such as the aminoglycosides (12) , tetracyclines (23) , and broad spectrum penicillins (22) were included in some of these studies.
In this paper, we present data on the comparative susceptibility of recent Immunotyping of selected strains was performed in the laboratory of M. W. Fisher, Parke, Davis & Co., Detroit, Mich., by the method which he and his co-workers described (6) .
RESULTS
Sources of the strains. The sources of the isolates are listed in Table 1 . Although the lower respiratory tract accounted for 40% of the strains, the majority of strains from this source did not occur in pure culture and were usually not associated with pneumonia. Only 20% of the respiratory isolates grew out in pure culture or were associated with significant clinical infection of the respiratory tract. Infections of the urinary tract accounted for 23% of the isolates and postoperative wounds for another 11 %. Blood cultures were positive in 10 of the 163 patients. Nearly 80% of the isolates were acquired in the hospital; only those strains recovered from skin and subcutaneous infections were predominantly community-acquired. Only one isolate from each patient was included. Susceptibility to antibiotics. The upper panel of Fig. 1 shows the susceptibility of the strains of P. aeruginosa to polymyxin B, gentamicin, and five penicillins, when using a 10-1 dilution of culture as inoculum. Polymyxin B was the most active agent, the median MIC being 1.6 ,ug/ml; only two strains were not inhibited by 6.25 ug/ ml. Gentamicin was nearly as active as polymyxin B, the MIC values ranging from 0.1 to 25 ,g/ml (median, 3.1 ,ug/ml).
AB-2288 (also designated BRL-2288) was the most active of the five penicillins tested; the median of the 163 isolates tested was 12.5 jug/ml (range 0.1 to >400 ,ug/ml). It was generally four times more active than either carbenicillin and BLP-1654, both of which were about equally active against a 10-3 dilution of culture; only 3% of strains were resistant to 400 jig/ml or more of any of these three agents.
The lower panel of the figure shows the influence of inoculum size on the MIC of each antibiotic for 31 randomly selected strains tested in parallel. A twofold increase in the median MIC for polymyxin B and gentamicin was demonstrated. A more marked inoculum effect was noted with the penicillins; one-half of the strains were resistant to 400 jug/ml or more of carbenicillin and AB-2288, and 82% of the strains were resistant to similar concentrations of BLP-1654 when the undiluted inoculum was used. The results obtained with 31 isolates, using undiluted cultures with penicillin G and ampicillin, are not shown; these two penicillins were essentially in-871 VOL. 22, 1971 (11) , no appreciable change in the susceptibility of P. aeruginosa to gentamicin over this 6-year period is noted. One reason for this lack of development of significant resistance may be that topical gentamicin is seldom or never used at this hospital. Workers Carbenicillin, AB-2288, and BLP-1654 differ from other penicillins in being active against P. aeruginosa and also against both indolenegative and -positive strains of Proteus. Structurally, AB-2288 resembles carbenicillin and BLP-1654 is related to ampicillin. Of the three new compounds, BLP-1654 was the least active in vitro against all species of Proteus (2), and it was quantitatively similar to carbenicillin in its activity against P. aeruginosa when tested with a dilute inoculum; however, it was essentially inactive against most strains when tested with an undiluted inoculum. AB-2288 was four times more active than carbenicillin when tested with a dilute inoculum, but these two penicillins were more nearly equal in activity when tested against undiluted cultures. Quantitatively the results obtained in this study with the diluted inoculum were similar to those reported by Smith and Finland (20) who noted a greater inoculum effect than was found in the present study. The median MIC of carbenicillin for P. aeruginosa, namely 50 ,ug/ml, is readily achieved in the serum when large intravenous doses are administered (20 to 40 g daily); more than 90% of strains were inhibited by 50 ,ug or less of carbenicillin per ml. In addition, Smith et al. (19) demonstrated that carbenicillin and gentamicin were synergistic in vitro against many strains of P. aeruginosa, and polymyxin and carbenicillin also acted synergistically against many other strains.
Because of the resistance of P. aeruginosa to most antibiotics, or the necessity to resort to toxic drugs, other means of treating these infections have been investigated. One therapeutic device makes use of a combination of a penicillinase inhibitor or a penicillinase-resistant penicillin such as methicillin or cloxacillin, and another penicillin which is sensitive to penicillinase such as ampicillin or benzylpenicillin (16, 17, 18) . The penicillinase-resistant drug preferentially binds to the penicillinase elaborated by the organism, allowing the other penicillin to inhibit cell wall synthesis without itself being destroyed.
With the recognition that the majority of nosocomial infections are currently caused by gram-negative bacilli, it has become necessary, for epidemiological purposes, to utilize more precise methods of identifying and classifying these organisms. Bacteriocines and serological methods of typing have emerged as useful in the classification of strains of P. aeurginosa. Gillies and Govan (8) showed that pyocin typing is a valid and sensitive method of classifying P. aeruginosa for epidemiological purposes. They differentiated 37 specific pyocin types and have also been able to subclassify type 1, the most common type in their studies, into eight subtypes (9) . Several "immunotypes" based on specific "protective" antigens have also been delineated (6) and used for epidemiological purposes (M. R. Moody and V. M. Young, personal communication) and also as a basis for the development of a heptavalent Pseudomonas vaccine (10) . (8, 9) . A larger percentage of the present strains that were tested could be classified by immunotyping than by pyocin typing (88% versus 57%). Immunotype 3 accounted for 27% of the typable strains and was composed of strains of a variety of pyocin types, which, in turn, were both hospital-acquired and community-acquired and were evenly distributed among various anatomic sites of infection.
The data suggest that, in this hospital, immunotypes 2 and 4 were more frequently associated with a respiratory site than with other anatomic foci; no other significant differences among infections in various sites were identified. However, Moody and co-workers (personal communication) found that within their hospital certain immunotypes had a specific predilection for various sites of infection. Thus, blood stream invasion was most frequent with immunotypes 2 and 7; these two types were not frequently associated with infections of the respiratory or the urinary tract, whereas types 3 and 6 were significantly associated with upper respiratory tract infections but not with postoperative wound infections or bacteremia.
Phage typing was not carried out in the present study, although an earlier one by Postic and Finland (15) suggested the feasibility and possible usefulness of this method for epidemiological purposes.
